O'Keefe Kenneth W's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Aug 9, 2022
- Accession no.
- 0001765581-22-000092
- Filed
- Aug 9, 2022
- Trade date
- Aug 5-8, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $165.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Keefe Kenneth WCIK 0001397661 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2022 | Ordinary Shares | AGrant or awardAcquired | +2,561 | $0.00 | $0 | 22,168 | Direct | |
| Aug 8, 2022 | Ordinary Shares | SSaleDisposed | −1,089 | $152.33 | −$165,887.37 | 21,079 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.